Olivier Biebuyck - Nov 3, 2023 Form 4 Insider Report for ESAB Corp (ESAB)

Signature
/s/ Curtis E. Jewell, Attorney-in-Fact
Stock symbol
ESAB
Transactions as of
Nov 3, 2023
Transactions value $
-$83,029
Form type
4
Date filed
11/6/2023, 06:00 PM
Previous filing
Sep 19, 2023
Next filing
Nov 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ESAB Common stock, par value $.001 Options Exercise $67K +2K +31.05% $33.49 8.44K Nov 3, 2023 Direct
transaction ESAB Common stock, par value $.001 Tax liability -$107K -1.43K -16.93% $75.01 7.01K Nov 3, 2023 Direct F1
transaction ESAB Common stock, par value $.001 Sale -$42.8K -571 -8.14% $74.99 6.44K Nov 3, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ESAB Employee Stock Option (right to buy) Options Exercise $0 -2K -52.51% $0.00 1.81K Nov 3, 2023 Common stock, par value $0.001 2K $33.49 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Represents shares withheld by ESAB Corporation in connection with net share settlement to satisfy the tax liability and exercise price associated with the reporting person's exercise of employee stock options. No shares were sold by the reporting person to satisfy the exercise price or this tax liability.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.